Establishment Labs Q3 revenue rises 33.9% to $72.0 million; full-year guidance raised
Establishment Labs reported third-quarter 2026 revenue of $72.0 million, up 33.9% from a year earlier, with U.S. revenue up 119.0% to $26.0 million. The company also raised its full-year 2026 revenue guidance to more than $274 million, from $269 million to $271 million, and reported its first positive quarter of free cash flow, which matters to shareholders because it shows higher sales and a narrower loss.
Key points
- Q3 2026 revenue was $72.0 million versus $53.8 million in Q3 2025; GAAP net loss narrowed to $10.7 million, or $(0.35) per share, from $11.1 million, or $(0.38) per share.
- Adjusted EBITDA was $6.4 million, or 8.9% of revenue, compared with $1.2 million a year earlier.
- Free cash flow was $5.1 million in the quarter, the first positive quarter in the company's history.
- Full-year 2026 revenue guidance was raised to more than $274 million; adjusted operating expense guidance of $195 million to $200 million was unchanged.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.